**Question:** NESTROFT test is used for screening of

A. Diabetes mellitus
B. Chronic kidney disease
C. Hypertension
D. Chronic obstructive pulmonary disease (COPD)

**Correct Answer:** D. Chronic obstructive pulmonary disease (COPD)

**Core Concept:**
The NESTROFT test stands for Nicotinic Acid, Echocardiography, Serum Triglycerides, Renal Function, Thyroid Function, Vascular Disease, and Fatigue. It is a screening tool used to assess cardiovascular risk factors and identify patients who may benefit from statin therapy to reduce the risk of cardiovascular events.

**Why the Correct Answer is Right:**
NESTROFT primarily assesses cardiovascular risk factors, focusing on the following components:

1. Nicotinic acid: Evaluates the presence of hyperlipidemia and is used to assess the efficacy of statin therapy.
2. Echocardiography: Assesses cardiac function and detects structural abnormalities that increase cardiovascular risk.
3. Serum triglycerides: Indicates dyslipidemia and is a marker for cardiovascular risk.
4. Renal Function: Assesses renal function and is crucial for identifying patients with an increased risk of cardiovascular events due to impaired renal function.
5. Thyroid Function: Assesses thyroid function, which can affect cardiovascular risk indirectly through its impact on heart rate, blood pressure, and overall cardiovascular health.
6. Vascular Disease: Screens for vascular disease, which is a significant contributor to cardiovascular risk.
7. Fatigue: Assesses the patient's subjective experience of fatigue, which can be a symptom of various conditions and indicates a need for further evaluation and intervention.

**Why Each Wrong Option is Incorrect:**

A. Diabetes mellitus (option A) is not an essential component of the NESTROFT test. The test focuses on cardiovascular risk factors, not diabetes-related factors.

B. Chronic kidney disease (option B) is not the primary focus of the NESTROFT test. The test assesses cardiovascular risk factors and assesses renal function, but it does not primarily evaluate chronic kidney disease.

C. Hypertension (option C) is not a primary component of the NESTROFT test. The test assesses cardiovascular risk factors and renal function but does not directly screen for hypertension.

D. Chronic obstructive pulmonary disease (COPD) (option D) is a significant component of the NESTROFT test. The test evaluates cardiovascular risk factors, including COPD, which is a cause of cardiovascular risk and may benefit from statin therapy. In this context, the correct answer is COPD (option D), as it is an essential component of the NESTROFT test that assesses cardiovascular risk factors and identifies patients who may require statin therapy to reduce cardiovascular risk.

**Clinical Pearl:**

NESTROFT is a comprehensive cardiovascular risk assessment tool used in clinical practice to identify patients who may benefit from statin therapy to reduce cardiovascular risk. By evaluating various risk factors, including COPD, the test helps healthcare professionals optimize treatment strategies and improve patient outcomes.